Cathie Wood's ARK Invest Sells Over 125,000 Shares of Iovance Bio

Investing

Published: August 26, 2021 8:45 am

One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.

Check out all of the ARK Invest sales for Wednesday:

Fund	Ticker	Name	Shares
ARKF	3690HK	MEITUAN	1,342,426
ARKF	9923HK	YEAHKA	339,600
ARKF	6060HK	ZHONGAN ONLINE P&C INSURANCE	1,339,400
ARKG	SEER	SEER	152,557
ARKG	RHHBY	ROCHE	66,000
ARKG	PSTI	PLURISTEM THERAPEUTICS	16,223
ARKG	BMY	BRISTOL-MYERS SQUIBB	114,400
ARKK	IOVA	IOVANCE BIOTHERAPEUTICS	128,163
ARKK	NTDOY	NINTENDO	53,300
ARKQ	XONE	EXONE	82,333
ARKW	LC	LENDINGCLUB	164,932
ARKW	NFLX	NETFLIX	192

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
Goldman Sachs Says Buy These 4 Top Oil Stocks With Huge 2022 Upside Potential

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.

Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.